These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy. Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605 [TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition as an adjuvant anticancer therapy: it is more than just a waiting game. Elmore LW; Holt SE Expert Opin Ther Targets; 2007 Apr; 11(4):427-30. PubMed ID: 17373872 [TBL] [Abstract][Full Text] [Related]
6. Telomere maintenance as a target for drug discovery. Sekaran V; Soares J; Jarstfer MB J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596 [TBL] [Abstract][Full Text] [Related]
8. Telomere biology of pediatric cancer. Tabori U; Dome JS Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490 [TBL] [Abstract][Full Text] [Related]
9. Anticancer therapy targeting telomeres and telomerase : current status. Parkinson EK; Minty F BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621 [TBL] [Abstract][Full Text] [Related]
10. Cancer. Cancer and telomeres--an ALTernative to telomerase. Shay JW; Reddel RR; Wright WE Science; 2012 Jun; 336(6087):1388-90. PubMed ID: 22700908 [No Abstract] [Full Text] [Related]
11. Telomere recombination and the ALT pathway: a therapeutic perspective for cancer. Draskovic I; Londono-Vallejo A Curr Pharm Des; 2014; 20(41):6466-71. PubMed ID: 24975611 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for targeting telomerase in cancer. Chen X; Tang WJ; Shi JB; Liu MM; Liu XH Med Res Rev; 2020 Mar; 40(2):532-585. PubMed ID: 31361345 [TBL] [Abstract][Full Text] [Related]
13. Highlights in experimental therapeutics. Burger AM Cancer Lett; 2007 Jan; 245(1-2):11-21. PubMed ID: 16647200 [TBL] [Abstract][Full Text] [Related]
14. Telomeres and telomerase: Biological and clinical importance in dogs. Nasir L Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127 [TBL] [Abstract][Full Text] [Related]
15. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer. Sekhri K J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
17. Targeting the telosome: therapeutic implications. Folini M; Gandellini P; Zaffaroni N Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699 [TBL] [Abstract][Full Text] [Related]
18. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747 [TBL] [Abstract][Full Text] [Related]
19. Targeting cancer with telomerase: commentary re Q. Huang et al., a novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells. Clin. Cancer Res., 10: 1439-1445, 2004. Hahn WC Clin Cancer Res; 2004 Feb; 10(4):1203-5. PubMed ID: 14977815 [No Abstract] [Full Text] [Related]
20. Telomerase inhibition as cancer therapy. Saretzki G Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]